KBI Biopharma

KBI Biopharma is a premier contract development and manufacturing organization (CDMO) specializing in comprehensive biopharmaceutical services to advance drug development and commercialization. We offer a full spectrum of services, including advanced mammalian cell line development for high-yield, stable cell lines, and customized biopharmaceutical process development solutions for upstream and downstream processes. Our analytical development ensures the quality and safety of your products through robust testing methods, while our formulation development enhances stability and efficacy. We provide in-depth characterization of biologics using advanced analytical techniques and support your clinical programs with flexible mammalian clinical manufacturing services. Additionally, our expertise in cell culture maximizes productivity and product quality.